Roivant Sciences Ltd (ROIV)

Sector:Health Care
Super Investor Stats:
Ownership count:3
Ownership rank:299
% of all portfolios:0.037%
Hold Price * :$27.70
History Portfolio Manager Activity Share change % change to portfolio ▼
Q1  2026
≡ Lee Ainslie - Maverick Capital Buy 1,626,940 0.52
≡ David Einhorn - Greenlight Capital Add 4.03% 83,360 0.07
≡ Viking Global Investors Add 3.25% 209,257 0.02
≡ Polen Capital Management Sell 100.00% 9,662 0.00
Q4  2025
≡ Viking Global Investors Reduce 72.69% 17,151,640 0.98
≡ David Einhorn - Greenlight Capital Reduce 9.06% 206,220 0.16
≡ Polen Capital Management Buy 9,662 0.00
Q3  2025
≡ David Einhorn - Greenlight Capital Reduce 50.00% 2,275,528 1.35
≡ Viking Global Investors Reduce 31.09% 10,642,948 0.42
Q2  2025
≡ David Einhorn - Greenlight Capital Reduce 16.36% 890,110 0.43
≡ Viking Global Investors Reduce 25.59% 11,775,973 0.39
Q1  2025
≡ David Einhorn - Greenlight Capital Add 3.23% 170,100 0.09
≡ Viking Global Investors Reduce 3.76% 1,796,208 0.06
Q4  2024
≡ Viking Global Investors Reduce 11.63% 6,289,106 0.24
≡ David Einhorn - Greenlight Capital Reduce 0.70% 36,973 0.02
Q3  2024
≡ Viking Global Investors Reduce 21.77% 15,056,780 0.63
≡ David Einhorn - Greenlight Capital Add 10.33% 497,080 0.24
Q2  2024
≡ David Einhorn - Greenlight Capital Add 14.81% 620,470 0.32
≡ Viking Global Investors Reduce 0.31% 213,115 0.01
Q1  2024
≡ David Einhorn - Greenlight Capital Buy 4,190,490 2.02
Q4  2023
≡ Viking Global Investors Reduce 5.54% 4,065,340 0.17
Q3  2023
≡ Viking Global Investors Reduce 2.40% 1,804,399 0.09
Q2  2023
≡ Viking Global Investors Reduce 14.73% 13,000,000 0.54
Q4  2021
≡ Viking Global Investors Buy 88,238,700 2.58

* "Hold Price" is the last known price at which an investor still held a security. It is the closing price of the security as of the portfolio date (quarter end). This value is only provided when a security is owned by at least two investors. In the case of reporting dates being different, a weighted average price is calculated.